Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Semaglutide vs Lifestyle in Adolescent PCOS (TEAL)
NCT03919929Phase 3Completed
- Sponsor
- University of Colorado Denver
- Start
- May 2019
- Primary completion
- Oct 2023
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of semaglutide in polycystic ovary syndrome (PCOS), obesity, non-alcoholic fatty liver disease (NAFLD), sponsored by University of Colorado Denver. Started May 2019; status: completed.
02
Drugs
03
Conditions
polycystic ovary syndrome (PCOS)obesitynon-alcoholic fatty liver disease (NAFLD)
Beyond the preview
Go deeper on NCT03919929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03919929.